Evidence Sheet: Microsoft (MSFT)
The standing BullScope yardsticks for Microsoft, computed from official filings and refreshed with each new edition.
Moe Alsumidaie, MBA, MSF is the Chief Editor of BullScope. Trained in finance, with a Master of Science in Finance and an MBA, he spent years inside large public healthcare companies including Abbott, Genentech, and Roche, learning how the businesses behind the filings actually run. As a journalist and Chief Editor of The Clinical Trial Vanguard, his reporting has appeared in Applied Clinical Trials, The American Journal of Managed Care, and CNET, and has been cited in U.S. Supreme Court proceedings. At BullScope he brings those disciplines together: every note starts in the SEC filings, runs through published methodology, and shows its work.
The standing BullScope yardsticks for Microsoft, computed from official filings and refreshed with each new edition.
According to post-earnings coverage, sell-side analysts at multiple firms raised their price targets following Amazon's Q2 2026 results on July...
Three years ago, Microsoft was a mature software giant with respectable but predictable margins, a cloud business growing fast enough...
The standing BullScope yardsticks for Walmart, computed from official filings and refreshed with each new edition.
In one breath Walmart's filed numbers show a business earning more from each dollar of sales than at any point...
In one breath The BEA's advance estimate for Q2 2026, released July 30, shows the economy growing at 1.5% annually,...
In one breath Meta's revenue is growing faster than almost anyone expected. Its profit, for this quarter, is not. The...
The standing BullScope yardsticks for Tesla, computed from official filings and refreshed with each new edition.
In 2009, Visa was barely a public company, freshly listed after decades as a bank-owned cooperative. It had a simple...
One number stops the conversation cold. Tesla's current P/E ratio, the price a buyer pays per dollar of annual profit,...
© 2026 BullScope. Evidence-first investment research. Not investment advice. · Methodology · Privacy Policy · Terms of Use · Disclaimer
© 2026 BullScope. Evidence-first investment research. Not investment advice. · Methodology · Privacy Policy · Terms of Use · Disclaimer